Elicit: Efficacy of SGLT Activators on Water Absorption (public)
How effective are sodium-glucose cotransport activators in improving water absorption?
Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.
Abstract
Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.
Methods
We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.
Papers identified with Elicit search
- n = 997
Papers screened using: SGLT Activators/Enhancers, Water Absorption Outcome, In Vivo Studies, Appropriate Study Design, SGLT Activators vs Inhibitors, Beyond In Vitro Only, Publication Quality
- n = 997
Papers screened out
- n = 968
Papers included for extraction
- n = 29
Results
Characteristics of Included Studies
| Study | Study Design | Clinical Condition | Intervention Type | Primary Outcome Measure |
|---|---|---|---|---|
| Wapnir et al., 1988 | Animal experimental study | Osmotic diarrhea (rats) | L-alanine, protein hydrolysate in oral hydration solution | Water and sodium absorption |
| Rongione et al., 2001 | Animal experimental; in vivo physiological | Normal dogs | Epidermal Growth Factor (EGF), Transforming Growth Factor (TGF) | Sodium, chloride, water, glucose absorption |
| Aguero et al., 1990 | Animal experimental; in vivo physiological | Normal and diarrheic Wistar rats | Glutamine in World Health Organization Oral Rehydration Solution | Sodium and water absorption |
Water Absorption Outcomes
| Study | Activator Type | Water Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased water absorption | “Very significant increase” | No mention found |
| Aguero et al., 1990 | Glutamine | Increased water absorption | Not quantified | Not significant (p>0.05) |
| Elliott et al., 1986 | Glucose (oral rehydration solution) | Increased water absorption | +98.6±16 microliters/minute/gram (ratio 1.9) | p<0.01 |
Sodium Absorption Outcomes
| Study | Activator Type | Sodium Absorption Effect | Effect Size | Statistical Significance |
|---|---|---|---|---|
| Wapnir et al., 1988 | L-alanine, protein hydrolysate | Increased sodium absorption | “Very significant increase” | No mention found |
| Grahammer et al., 2006 | Dexamethasone | Increased SGLT1/NHE3 activity | Approximately 3x increase (wild type) | Significant (no further details in abstract) |
Context-Dependent Effects and Generalizability
- Most evidence is from animal models, limiting direct translation to human clinical settings.
- The magnitude of effect was often greater in diarrheal or secretory models than in healthy controls.
- Optimal glucose:sodium ratio, osmolality, and inclusion of amino acids or polymers were reported as critical for maximizing absorption in several studies.
- Hormonal and pharmacological modulation were reported to affect SGLT1 activity.
References
- J. Turner, David E. Cohen, R. Mrsny, J. Madara (2000). Noninvasive In vivo Analysis of Human Small Intestinal Paracellular Absorption: Regulation by Na+-Glucose Cotransport. Digestive Diseases and Sciences
- A. Rongione, A. Kusske, T. Newton, S. Ashley, M. Zinner, and 1 more (2001). EGF and TGF Stimulate Proabsorption of Glucose and Electrolytes by Na+/Glucose Cotransporter in Awake Canine Model. Digestive Diseases and Sciences.